A team comprising data scientists and cancer researchers has devised an algorithm that could eventually be used to determine the cause of brain tumors and…
Uber and its rival Lyft were both at DPharm Disruptive Innovation US to pitch themselves as the answer to an enduring inefficiency in clinical trials.
Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
Researchers have found 110 antiviral targets and several existing drugs that may hit them using gene-trap insertional mutagenesis and a computational framework…
Illumina has agreed to comarket Dovetail Genomics’ genome assembly service, an offering that leverages short-read sequencers to deliver long-range information.
Jun Wang’s iCarbonX has dipped into its Series A haul to buy Imagu Vision, an Israeli startup active in identifying and analyzing medical images.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
In a recent effort to characterize new targets of obesity, a collaborative effort has suggested a new mechanism that regulates obesity in the mouse’s brain.
A consortium of cancer centers has contracted HudsonAlpha Institute of Biotechnology to sequence 20,000 samples by 2019.